Clinical Trials Directory

Trials / Completed

CompletedNCT06690268

Multimodal Model Predicts Recurrence

Multimodal Clinical-imaging-pathology-driven Artificial Intelligence Model for Predicting Postoperative Recurrence of Locally Advanced Gastric Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
93 (actual)
Sponsor
Qun Zhao · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study focuses on developing an advanced model that combines clinical information, imaging, and pathology data to predict the likelihood of cancer returning after surgery in patients with locally advanced gastric cancer. By using artificial intelligence (AI), this model analyzes various data sources to create a more accurate prediction of recurrence risk, which can help doctors, patients, and families better understand the chances of recurrence. This AI-driven approach allows healthcare providers to make more informed decisions about personalized follow-up care and potential additional treatments to improve patient outcomes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultimodal AI-driven predictive modelThis intervention involves a multimodal artificial intelligence (AI) model that integrates clinical data, imaging results, and pathology findings to predict the risk of postoperative recurrence in patients with locally advanced gastric cancer. Unlike traditional methods that may rely on single data sources, this AI-driven model synthesizes multiple types of patient information, offering a comprehensive and personalized prediction of recurrence risk. This approach aims to improve accuracy in identifying high-risk patients, allowing for more tailored follow-up and treatment planning to enhance patient outcomes.

Timeline

Start date
2022-01-01
Primary completion
2024-10-31
Completion
2024-10-31
First posted
2024-11-15
Last updated
2024-11-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06690268. Inclusion in this directory is not an endorsement.